Unknown PHASE2/PHASE3 INTERVENTIONAL 2-arm NCT02034539

VADOplex Critical Limb Ischemia Study

Prospektive, Randomisierte Und Kontrollierte Studie Zum Einfluss Des VADOplex-Systems Auf Die Lebensqualität im Rahmen Der Behandlung Der Chronisch-kritischen Extremitätenischämie im Stadium IV Nach Fontaine

Sponsor: Asklepios Kliniken Hamburg GmbH

Conditions Peripheral Artery Disease Quality of Life Wound Healing

Interventions VADOplex system

Updated 5 times since 2017 Last updated: Jan 10, 2014 Started: Oct 31, 2013 Primary completion: Oct 31, 2014 Completion: Nov 30, 2014

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT02034539, this PHASE2/PHASE3 trial focuses on Peripheral Artery Disease and Quality of Life and remains ongoing. Sponsored by Asklepios Kliniken Hamburg GmbH, it has been updated 5 times since 2013, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE2/PHASE3
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE2/PHASE3

Status: Unknown Status → Unknown · Phase: PHASE2_PHASE3 → PHASE2/PHASE3
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE2_PHASE3
Feb 2017 — Jan 2021 [monthly]

Unknown Status PHASE2_PHASE3
Jan 2017 — Feb 2017 [monthly]

Unknown Status PHASE2_PHASE3

First recorded

Oct 2013

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Asklepios Kliniken Hamburg GmbH
OPED GmbH

Data source: Asklepios Kliniken Hamburg GmbH

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Hamburg, Germany